COPD Medication Study

Now Enrolling Adults Ages 40 to 80

● Now Enrolling

About this research study

Chronic obstructive pulmonary disease (COPD) is a group of diseases that cause airflow blockage and breathing problems. Symptoms of COPD include coughing or wheezing, shortness of breath, trouble taking a deep breath, and excess phlegm.

Velocity is now enrolling people for a study of an investigational medication for COPD in patients with COPD who have exertional breathlessness despite treatment with mono or dual COPD maintenance therapy.

Eligible participants...

Must be ages 40 to 80
Must have a diagnosis of COPD
Must be a current or former smoker
Must be on mono or dual inhaled maintenance COPD treatment at a stable dose for the past 4 weeks
Must NOT have a current diagnosis of any other chronic respiratory diseases other than COPD
Will receive compensation for study-related time

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

More information about participating in a clinical trial...

After you submit your information, a Velocity enrollment specialist will contact you.

Participating in a study is an important decision — we’re here to help you before, during, and after studies.

Please note: Health insurance is NOT required to join.

Is participation voluntary after I submit my information?

Yes. Participation in a study is entirely voluntary. In the informed consent process, you’ll learn about the product being studied, the participant’s role in the study, potential side effects, the number of visits that may be required, and more. Participants must sign an informed consent form to join the study.

Will I receive compensation?

While participation in a clinical study is voluntary, you may be paid for study-related time. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. Staff at the research clinic will discuss possible payment with you.

Enter your info

Name(Required)

Phone(Required)

Date of birth(Required)

Age can help us determine study eligibility (you must be age 18 or older to submit this form).

Month

Day

Year

Location and study of interest(Required)

Gender

Preferred language

Are you Hispanic or Latino?(Required)

Race(Required)

Select one or more designations that best describe you. This information can help Velocity better ensure all populations are represented in research.

American Indian or Alaskan Native

Asian

Black or African American

Native Hawaiian or Other Pacific Islander

White or Caucasian

This field is hidden when viewing the form

MobileOptIn

By entering your email address and/or phone number on this form, you represent that you are at least 18 years of age and consent to receiving communications (e.g., call, SMS, text, and/or email) from Velocity and/or the research site(s) involved with the clinical trials that appear on this website. Messaging frequency varies. Message and data rates may apply. You may reply with STOP to a text message. For any help regarding messaging, please email us at [email protected]. For full details, refer to Velocity's privacy policy and website terms of use. Submissions on this website are not monitored 24/7. Do NOT submit personal health or medical information on this form. If you are enrolled in a trial and have questions, please call your research site.

Comments

This field is for validation purposes and should be left unchanged.

Study Locations

Gaffney, South Carolina • Velocity Clinical Research

1529 N. Limestone Street, Gaffney, SC 29340
Phone: (864) 488-1283

Medford, Oregon • Velocity Clinical Research

3121 Signature Court, Medford, OR 97504
Phone: (541) 858-1018